Curidium works with partner companies to apply Curidium’s platform, Homomatrix®, to develop and license diagnostic tests such as PsychINDx™ and other intellectual property (IP) to aid with drug development and discovery.
Contact Details:
Mr Nathan Caffo
VP Business Development
Curidium Medica
Studio 10
Tiger House
Burton Street
London WC1H 9BY
businessdevelopment@curidium.com
Tel: +44 20 7554 5100
